These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

633 related articles for article (PubMed ID: 20054047)

  • 1. Clinical practice. Stage IV chronic kidney disease.
    Abboud H; Henrich WL
    N Engl J Med; 2010 Jan; 362(1):56-65. PubMed ID: 20054047
    [No Abstract]   [Full Text] [Related]  

  • 2. Anemia normalization in patients with type 2 diabetes and chronic kidney disease: results of the NEPHRODIAB2 randomized trial.
    Villar E; Lièvre M; Kessler M; Lemaître V; Alamartine E; Rodier M; François M; Zaoui P; Moranne O; Choukroun G; Guerraoui A; Jolivot A; Janin G; Branger B; Heng AE; Boudray C; Bissery A; Rabilloud M; Pouteil-Noble C
    J Diabetes Complications; 2011; 25(4):237-43. PubMed ID: 21601481
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Renoprotection by blockade of the renin-angiotensin-aldosterone system in diabetic and non-diabetic chronic kidney disease. Specific involvement of intra-renal angiotensin-converting enzyme activity in therapy resistance?
    Vogt L; Kocks MJ; Laverman GD; Navis G
    Minerva Med; 2004 Oct; 95(5):395-409. PubMed ID: 15467515
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemia and cardiovascular risk in type 2 diabetes mellitus patients with associated diabetic nephropathy].
    Martínez-Castelao A; Ramos R; González MT; Castiñeiras MJ
    Nefrologia; 2002; 22 Suppl 1():51-8. PubMed ID: 11987671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Control of arterial pressure in diabetic nephropathy].
    Luño J; García de Vinuesa S
    Nefrologia; 2001; 21(3):240-5. PubMed ID: 11471304
    [No Abstract]   [Full Text] [Related]  

  • 6. Hypertension in diabetes mellitus.
    Hasslacher C; Ritz E; Tschöpe W; Gallasch G; Mann JF
    Kidney Int Suppl; 1988 Sep; 25():S133-7. PubMed ID: 3184604
    [No Abstract]   [Full Text] [Related]  

  • 7. Diabetic nephropathy in non-insulin dependent diabetes mellitus. Cardiovascular risk factors and antihypertensive treatment.
    Nielsen FS
    Dan Med Bull; 2000 Sep; 47(4):249-70. PubMed ID: 11064829
    [No Abstract]   [Full Text] [Related]  

  • 8. [Risk and prevention of diabetic nephropathy].
    Ravera M; Re M; Deferrari G
    G Ital Nefrol; 2007; 24 Suppl 38():13-9. PubMed ID: 17922442
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Slowing progression along the renal disease continuum.
    Kopyt NP
    J Am Osteopath Assoc; 2005 Apr; 105(4):207-15. PubMed ID: 15928338
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Risk of chronic renal failure in patients with non-insulin dependent diabetes mellitus with diabetic nephropathy and the stage of permanent proteinuria and arterial hypertension: role of clinical factors].
    Dobronravov VA
    Ter Arkh; 2000; 72(6):52-4. PubMed ID: 10900651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treating elderly people with diabetes and stages 3 and 4 chronic kidney disease.
    Abaterusso C; Lupo A; Ortalda V; De Biase V; Pani A; Muggeo M; Gambaro G
    Clin J Am Soc Nephrol; 2008 Jul; 3(4):1185-94. PubMed ID: 18417749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Managing advanced chronic kidney disease: a primary care guide.
    Sakhuja A; Hyland J; Simon JF
    Cleve Clin J Med; 2014 May; 81(5):289-99. PubMed ID: 24789588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can progression to terminal renal insufficiency be avoided in diabetic nephropathy?].
    Luño J; Valderrábano F
    An Med Interna; 1998 Nov; 15(11):567-71. PubMed ID: 9882851
    [No Abstract]   [Full Text] [Related]  

  • 14. Anemia development and cardiovascular risk management in nonanemic stage 3 chronic kidney disease.
    Portolés J; Castelao AM; Gorriz JL; Tato AM; de Alvaro F
    Ren Fail; 2009; 31(10):869-75. PubMed ID: 20030520
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improving care of patients with diabetes and CKD: a pilot study for a cluster-randomized trial.
    Cortés-Sanabria L; Cabrera-Pivaral CE; Cueto-Manzano AM; Rojas-Campos E; Barragán G; Hernández-Anaya M; Martínez-Ramírez HR
    Am J Kidney Dis; 2008 May; 51(5):777-88. PubMed ID: 18436088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Update on the management of chronic kidney disease.
    Rivera JA; O'Hare AM; Harper GM
    Am Fam Physician; 2012 Oct; 86(8):749-54. PubMed ID: 23062158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Natural history of immunoglobulin A nephropathy and predictive factors of prognosis: a long-term follow up of 204 cases in China.
    Lv J; Zhang H; Zhou Y; Li G; Zou W; Wang H
    Nephrology (Carlton); 2008 Jun; 13(3):242-6. PubMed ID: 18221258
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of gender, Helicobacter pylori and hepatitis B virus serology status on cardiovascular and renal complications in Chinese type 2 diabetic patients with overt nephropathy.
    Lo MK; Lee KF; Chan NN; Leung WY; Ko GT; Chan WB; So WY; Ng MC; Ho CS; Tam JS; Lam CW; Tong PC; Chan JC
    Diabetes Obes Metab; 2004 May; 6(3):223-30. PubMed ID: 15056131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predictive factors of progression to chronic kidney disease stage 5 in a predialysis interdisciplinary programme.
    Soares CM; Diniz JS; Lima EM; Oliveira GR; Canhestro MR; Colosimo EA; Simoes e Silva AC; Oliveira EA
    Nephrol Dial Transplant; 2009 Mar; 24(3):848-55. PubMed ID: 18840891
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Cardiovascular disorders and possibilities of their therapy in patients with type 2 diabetes mellitus and diabetic nephropathy].
    Onuchin SG; Elsukova OS; Solov'ev OV; Onuchina EL
    Klin Med (Mosk); 2010; 88(1):32-7. PubMed ID: 20369609
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.